Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CFO Steven Cook sold 23,263 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $22.76, for a total transaction of $529,465.88. Following the completion of the transaction, the chief financial officer owned 187,209 shares of the company’s stock, valued at approximately $4,260,876.84. The trade was a 11.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Omada Health Stock Performance
OMDA stock traded down $0.02 during midday trading on Wednesday, hitting $22.98. The company’s stock had a trading volume of 1,251,953 shares, compared to its average volume of 1,096,319. The firm’s 50-day moving average is $17.83 and its 200-day moving average is $15.27. Omada Health, Inc. has a 12 month low of $10.28 and a 12 month high of $26.92.
Omada Health (NASDAQ:OMDA – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The firm had revenue of $78.05 million during the quarter. As a group, research analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Omada Health
Analysts Set New Price Targets
A number of brokerages have recently issued reports on OMDA. Morgan Stanley reaffirmed an “overweight” rating and set a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Evercore restated an “outperform” rating and set a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Citigroup restated an “outperform” rating on shares of Omada Health in a report on Friday, May 8th. Citizens Jmp boosted their target price on shares of Omada Health from $18.00 to $21.00 and gave the company a “market outperform” rating in a research note on Friday, May 8th. Finally, Wells Fargo & Company raised their price target on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Ten investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Omada Health currently has an average rating of “Moderate Buy” and a consensus target price of $22.91.
About Omada Health
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Read More
- Five stocks we like better than Omada Health
- A Market Panic Just Discounted the AI Highway’s Tollbooth
- Why Exxon Could Be the Market’s Next Big Comeback Stock
- The Market Just Got Shaken—These 3 ETFs May Come Out Stronger
- Meta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
